Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dicerna Pharmaceuticals Inc (NASDAQ:DRNA)

9.69
Delayed Data
As of 11:36am ET
 +0.2499 / +2.65%
Today’s Change
2.42
Today|||52-Week Range
10.24
+236.45%
Year-to-Date
No recent news for Dicerna Pharmaceuticals Inc.

Today’s Trading

Previous close9.44
Today’s open9.52
Day’s range9.37 - 9.74
Volume35,282
Average volume (3 months)233,370
Market cap$196.8M
Dividend yield--
Data as of 11:36am ET, 11/24/2017

Growth & Valuation

Earnings growth (last year)+7.12%
Earnings growth (this year)-6.06%
Earnings growth (next 5 years)--
Revenue growth (last year)+60.33%
P/E ratioNM
Price/Sales202.28
Price/Book4.75

Competitors

 Today’s
change
Today’s
% change
LIFEaTyr Pharma Inc-0.05-1.27%
OPNTOpiant Pharmaceutica...-1.02-2.91%
FLKSFlex Pharma Inc+0.08+1.93%
CEMIChembio Diagnostics ...+0.15+2.24%
Data as of 11:35am ET, 11/24/2017

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)-$0.68
Annual revenue (last year)$295.0K
Annual profit (last year)-$59.5M
Net profit margin-20,173.90%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Douglas M. Fambrough
Senior Vice President-
Operations
David W. Miller
Corporate headquarters
Cambridge, Massachusetts

Forecasts